tm
Seeing Is Believing
tm
Seeing Is Believing
Kinnate Biopharma's activity chart (see below) currently has 32 price targets and 38 ratings on display.
Analysts average stock forecasts to be materialized ratio is 10.93% with an average time for these price targets to be met of 18.15 days.
Most recent stock forecast was given by from WELLS FARGO on 26-Feb-2024.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 17-Nov-2022
$2.59
$-0.06 (-2.26%)
$5.4
2 years 7 months 11 days ago
(26-Feb-2024)
1/7 (14.29%)
$0.14 (5.71%)
4
Hold Since 17-Jan-2024
$2
$-0.65 (-24.53%)
$2
2 years 8 months 20 days ago
(17-Jan-2024)
1/6 (16.67%)
$-0.36 (-15.25%)
57
Hold Since 10-Nov-2023
$4
$1.35 (50.94%)
$4
2 years 10 months 27 days ago
(10-Nov-2023)
0/7 (0%)
$2.77 (225.20%)
Buy Since 28-Sep-2021
$2
$-0.65 (-24.53%)
3 years 18 days ago
(19-Sep-2023)
1/2 (50%)
$0.5 (33.33%)
57
Buy Since 28-Jul-2022
3 years 18 days ago
(19-Sep-2023)
0/3 (0%)
$20.32 (552.17%)
What is KNTE (Kinnate Biopharma) average time for price targets to be met?
Which analyst most recently updated their price target on KNTE (Kinnate Biopharma)?
Which analyst has the most public recommendations on KNTE (Kinnate Biopharma)?
Which analyst is the currently most bullish on KNTE (Kinnate Biopharma)?
Which analyst is the currently most reserved on KNTE (Kinnate Biopharma)?
